UNSPSC 51401552: Talampanel

This classification denotes a cns stimulant with the molecular formula C19H19N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CVS43XG1L5, chemically known as 7h-1,3-dioxolo(4,5-h)(2,3)benzodiazepine, 8,9-dihydro-7-acetyl-5-(4-aminophenyl)-8-methyl-, (r)- but generally known as talampanel, which bears US NIH Compound Identifier 164509. The term TALAMPANEL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42).

Most nations schedule talampanel under HS 29349990 and SITC 51579. As of Q4 2014, TALAMPANEL remains the US FDA Preferred Term for this commodity. Talampanel bears US NLM identifiers UMLS ID C0250723 and NCI Concept Code C38139. SMILES: CC1CC2=CC3=C(C=C2C(=NN1C(=O)C)C4=CC=C(C=C4)N)OCO3.

UNSPSC 51401552 Talampanel is a Commodity code that does not match the work actually being solicited under it in recent state and local procurement activity. The single recent opportunity in the dataset — Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023 — sought to procure naloxone and safe drug deactivation systems, not talampanel (an oral anticonvulsant pharmaceutical). The mismatch suggests either a tagging error in the county's e-procurement system or that this code is used inconsistently across jurisdictions for pharmaceutical and medical-device procurement. The Seminole County solicitation calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building. Vendors must submit bids electronically through the county's e-Procurement Portal, include all shipping and delivery costs, comply with drug-free workplace certification and E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The contract term is two years with a one-year renewal option and includes a three-month probationary period. Potential FEMA funding introduces additional federal compliance requirements. The procurement does not specify set-asides for disadvantaged enterprises.

Given the single misaligned opportunity and the absence of other recent talampanel-specific solicitations in the dataset, this code shows little relevant recent activity for business development purposes. Firms interested in pharmaceutical and medical-device sales to state and local health departments should verify the correct UNSPSC classification through pre-bid contact with issuing agencies rather than rely on this code's current tagging patterns.